Gilman-Sachs A, Harris D, Beer A, Beaman K D
Department of Microbiology and Immunology, University of Health Sciences, Chicago Medical School, Illinois 60064.
J Reprod Immunol. 1990 Mar;17(1):41-51. doi: 10.1016/0165-0378(90)90038-8.
A two color flow cytometry crossmatch (FCXM) was used to evaluate the induction of anti-lymphocyte antibodies in 34 women undergoing immunotherapy for recurrent spontaneous abortions. All women had anti-lymphocyte antibodies that reacted with T-cells when analyzed by FCXM. However, inhibition of the binding of anti-CD3 to paternal CD3 lymphocytes in the presence of maternal antipaternal lymphocyte antiserum was found for some couples following lymphocyte immunotherapy for spontaneous recurrent abortions. Ten couples who had another spontaneous abortion following immunotherapy showed inhibition. In contrast, eight couples who did not show inhibition of the binding of anti-CD3 T lymphocytes to paternal lymphocytes by maternal anti-lymphocyte antiserum had live births. Women of the remaining 16 couples were either pregnant and awaiting birth or not pregnant. Thus, by FCXM it may be possible to predict those couples who will have successful pregnancies following this treatment.
采用双色流式细胞术交叉配型(FCXM)来评估34名接受复发性自然流产免疫治疗的女性体内抗淋巴细胞抗体的诱导情况。通过FCXM分析,所有女性均有与T细胞发生反应的抗淋巴细胞抗体。然而,在对部分因自然复发性流产接受淋巴细胞免疫治疗的夫妇中,发现母体抗父体淋巴细胞抗血清存在时,抗CD3与父体CD3淋巴细胞的结合受到抑制。10对在免疫治疗后再次发生自然流产的夫妇出现了抑制现象。相比之下,8对母体抗淋巴细胞抗血清未抑制抗CD3 T淋巴细胞与父体淋巴细胞结合的夫妇成功分娩。其余16对夫妇中的女性要么已怀孕待产,要么未怀孕。因此,通过FCXM有可能预测哪些夫妇在这种治疗后会成功受孕。